Core Viewpoint - Sinovac's seasonal flu vaccine has received official registration from the Ministry of Health and Prevention of the United Arab Emirates, marking a significant milestone for the company in expanding its vaccine portfolio and market reach [1]. Group 1: Company Developments - Sinovac's seasonal flu vaccine is now officially registered in the UAE, enhancing its credibility and market presence in the region [1]. - The vaccine has been widely used in over 20 countries and regions globally, indicating strong international demand and acceptance [1]. Group 2: Market Impact - The cumulative supply of Sinovac's seasonal flu vaccine has exceeded 120 million doses, showcasing the company's production capacity and distribution effectiveness [1].
科兴流感疫苗在阿拉伯联合酋长国获批注册